JP2022506044A5 - - Google Patents
Info
- Publication number
- JP2022506044A5 JP2022506044A5 JP2021523195A JP2021523195A JP2022506044A5 JP 2022506044 A5 JP2022506044 A5 JP 2022506044A5 JP 2021523195 A JP2021523195 A JP 2021523195A JP 2021523195 A JP2021523195 A JP 2021523195A JP 2022506044 A5 JP2022506044 A5 JP 2022506044A5
- Authority
- JP
- Japan
- Prior art keywords
- amino acids
- free amino
- amino acid
- free
- proline
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2025087837A JP2025128185A (ja) | 2018-10-30 | 2025-05-27 | 喘息またはｃｏｐｄを治療するためのアミノ酸組成物及び方法 |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201862752847P | 2018-10-30 | 2018-10-30 | |
| US62/752,847 | 2018-10-30 | ||
| PCT/US2019/058954 WO2020092639A1 (en) | 2018-10-30 | 2019-10-30 | Amino acid compositions and methods for treating cystic fibrosis |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2025087837A Division JP2025128185A (ja) | 2018-10-30 | 2025-05-27 | 喘息またはｃｏｐｄを治療するためのアミノ酸組成物及び方法 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2022506044A JP2022506044A (ja) | 2022-01-17 |
| JP2022506044A5 true JP2022506044A5 (https=) | 2022-11-09 |
| JP7689492B2 JP7689492B2 (ja) | 2025-06-06 |
Family
ID=70464502
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021523195A Active JP7689492B2 (ja) | 2018-10-30 | 2019-10-30 | 嚢胞性線維症を治療するためのアミノ酸組成物及び方法 |
| JP2025087837A Pending JP2025128185A (ja) | 2018-10-30 | 2025-05-27 | 喘息またはｃｏｐｄを治療するためのアミノ酸組成物及び方法 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2025087837A Pending JP2025128185A (ja) | 2018-10-30 | 2025-05-27 | 喘息またはｃｏｐｄを治療するためのアミノ酸組成物及び方法 |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US12220400B2 (https=) |
| EP (1) | EP3873453A4 (https=) |
| JP (2) | JP7689492B2 (https=) |
| KR (1) | KR20210086660A (https=) |
| CN (1) | CN113164425A (https=) |
| AU (2) | AU2019370363B2 (https=) |
| BR (1) | BR112021008395A2 (https=) |
| CA (1) | CA3116015A1 (https=) |
| MX (1) | MX2021005113A (https=) |
| WO (1) | WO2020092639A1 (https=) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA3177780A1 (en) * | 2020-05-29 | 2021-12-02 | University Of Florida Research Foundation, Inc. | Formulations and methods for treating acute respiratory distress syndrome, asthma, or allergic rhinitis |
| US11878073B1 (en) | 2022-09-20 | 2024-01-23 | Entrinsic, LLC | Generation of hydration-targeted formulations and methods of use therein |
Family Cites Families (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20030224071A1 (en) * | 1999-08-20 | 2003-12-04 | Howard Murad | Pharmaceutical compositions and methods for managing connective tissue ailments |
| WO2002098405A1 (fr) | 2001-06-05 | 2002-12-12 | Ajinomoto Co., Inc. | Inhibiteurs de fibrose du foie |
| ITTO20010804A1 (it) | 2001-08-08 | 2003-02-08 | Professional Dietetics Srl | Composizioni a base di aminoacidi, idonee alla terapia per la cicatrizzazione e/o riparazione di ferite e lesioni, in particolare per l'appl |
| WO2003055481A1 (en) | 2001-12-25 | 2003-07-10 | Ajinomoto Co., Inc. | Organ fibrosis inhibitors |
| AU2003223718B2 (en) * | 2002-04-25 | 2007-08-16 | The Scripps Research Institute | Treatment and prevention of pulmonary conditions |
| EP1513870A4 (en) * | 2002-05-31 | 2006-06-07 | Childrens Hosp Medical Center | CFTR MODIFIER GENES AND EXPRESSED POLYPEPTIDES USEFUL FOR TREATING MUCOVISCIDOSE AND TECHNIQUES AND PRODUCTS FOR DETECTING AND / OR IDENTIFYING THESE |
| AU2003901316A0 (en) * | 2003-03-21 | 2003-04-03 | The Royal Alexandra Hospital For Children | Regulation of cell surface proteins |
| US20040253319A1 (en) * | 2003-06-11 | 2004-12-16 | Shrirang Netke | Pharmaceutical compositions and method for alleviating side-effects of estrogen replacement therapy |
| US8389736B2 (en) | 2007-10-16 | 2013-03-05 | The Regents Of The University Of California | Compounds having activity in correcting mutant-CFTR processing and uses thereof |
| ITTO20080443A1 (it) | 2008-06-06 | 2009-12-07 | Professional Dietetics Srl | Composizioni comprendenti amminoacidi, con attivita' pro-angiogenica |
| EP2664326B1 (en) | 2012-05-17 | 2017-11-01 | I.E.R.F.C. European Institute for Cystic Fibrosis Research | Combined therapy for cystic fibrosis |
| US20140221424A1 (en) | 2013-01-30 | 2014-08-07 | Vertex Pharmaceuticals Incorporated | Pharmaceutical compositions for use in the treatment of cystic fibrosis |
| MA41031A (fr) * | 2014-11-26 | 2017-10-03 | Catabasis Pharmaceuticals Inc | Conjugués cystéamine-acide gras et leur utilisation comme activateurs de l'autophagie |
| WO2016191263A1 (en) | 2015-05-22 | 2016-12-01 | Trustees Of Dartmouth College | Therapy and kit for the prevention and treatment of cystic fibrosis |
| CA3001099A1 (en) * | 2015-10-09 | 2017-04-13 | Abbvie S.A.R.L. | Potentiator-corrector combinations useful in the treatment of cystic fibrosis |
| MA45397A (fr) * | 2016-06-21 | 2019-04-24 | Proteostasis Therapeutics Inc | Composés, compositions et procédés pour augmenter l'activité du cftr |
-
2019
- 2019-10-30 CA CA3116015A patent/CA3116015A1/en active Pending
- 2019-10-30 MX MX2021005113A patent/MX2021005113A/es unknown
- 2019-10-30 EP EP19879930.6A patent/EP3873453A4/en active Pending
- 2019-10-30 AU AU2019370363A patent/AU2019370363B2/en active Active
- 2019-10-30 US US17/289,374 patent/US12220400B2/en active Active
- 2019-10-30 WO PCT/US2019/058954 patent/WO2020092639A1/en not_active Ceased
- 2019-10-30 BR BR112021008395-2A patent/BR112021008395A2/pt not_active Application Discontinuation
- 2019-10-30 KR KR1020217015464A patent/KR20210086660A/ko active Pending
- 2019-10-30 CN CN201980077878.6A patent/CN113164425A/zh active Pending
- 2019-10-30 JP JP2021523195A patent/JP7689492B2/ja active Active
-
2025
- 2025-05-27 JP JP2025087837A patent/JP2025128185A/ja active Pending
- 2025-10-08 AU AU2025248660A patent/AU2025248660A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| TWI846239B (zh) | 病毒膜融合抑制劑的優化方法及廣效抗冠狀病毒脂肽和應用 | |
| JP2008536483A5 (https=) | ||
| JP2018520999A (ja) | 炎症および線維症のペプチド治療 | |
| US12503491B2 (en) | MASP inhibitory compounds and uses thereof | |
| JP2019533722A5 (https=) | ||
| JP2022506044A5 (https=) | ||
| EP4294454B1 (en) | Anti-viral peptides and compositions and methods of use thereof | |
| EP4617282A1 (en) | Membrane fusion inhibitor for inhibiting aids virus and drug-resistant strain thereof, and pharmaceutical use thereof | |
| CN110831957B (zh) | Apoc-ii模拟肽 | |
| CN102816215A (zh) | 抑制hiv的短小多肽及药物用途 | |
| WO2022200224A1 (en) | Compounds for use in the treatment of sinusitis, pneumonia or otitis | |
| JP2006524182A5 (https=) | ||
| JP2011501675A5 (https=) | ||
| JP2021531246A5 (https=) | ||
| US20190175688A1 (en) | Cyclic Peptides and Methods Using Same | |
| CA2990298C (en) | Agents for the treatment of retroviral infectious diseases | |
| US20200071357A1 (en) | Antimicrobial peptides | |
| WO2008050830A1 (fr) | Agent anti-vih | |
| JPH03504722A (ja) | Ｈｉｖ誘導細胞融合およびシンシチウム形成に対するペプチド阻害剤 | |
| CA3273216A1 (en) | Membrane fusion inhibitor for inhibiting aids virus and drug-resistant strain thereof, and pharmaceutical use thereof | |
| OA22102A (en) | Membrane fusion inhibitor for inhibiting aids virus and drug-resistant strain thereof, and pharmaceutical use thereof. | |
| US20070134221A1 (en) | Stabilizing peptides | |
| WO2013127299A1 (zh) | 用于抑制hiv的多肽及其作用靶点 | |
| HK40066330A (zh) | Masp抑制化合物及其用途 | |
| HK40066330B (zh) | Masp抑制化合物及其用途 |